Integer Holdings (ITGR) Liabilities from Discontinued Operations (2017 - 2024)
Integer Holdings' (ITGR) quarterly Liabilities from Discontinued Operations came in at $5.0 million in Q3 2024, up 41.85% quarter-over-quarter from $3.5 million in Q4 2023.
Powered by 
Analysis
Integer Holdings (ITGR) Liabilities from Discontinued Operations (2017 - 2024) Analysis & Trends
Integer Holdings has disclosed Liabilities from Discontinued Operations across 4 years of filings, most recently posting $5.0 million for Q3 2024.
- In Q3 2024, Liabilities from Discontinued Operations changed N/A year-over-year to $5.0 million; the TTM figure through Sep 2024 stood at $5.0 million (changed N/A YoY), while the FY2023 annual figure was $3.5 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $5.0 million for Q3 2024 at Integer Holdings, up from $3.5 million in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $5.0 million in Q3 2024 to a low of $3.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Integer Holdings | 4.29 Bn | 4.27 Bn | 112.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2024 | 4.97 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Jun 29, 2018 | 56.24 Mn |
| Dec 29, 2017 | 47.70 Mn |